carbostyril has been researched along with Adenocarcinoma of Lung in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, BC; Jang, KW; Kang, CW; Kang, HN; Kim, DJ; Kim, H; Kim, HR; Kim, JH; Kim, SM; Lim, SM; Moon, YW; Paik, S; Pyo, KH; Sohn, J; Yun, MR | 1 |
1 other study(ies) available for carbostyril and Adenocarcinoma of Lung
Article | Year |
---|---|
Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Apoptosis; Benzimidazoles; Catalytic Domain; Cell Cycle Checkpoints; Cell Line, Tumor; Drug Resistance, Neoplasm; Enzyme Activation; HEK293 Cells; Humans; Inhibitory Concentration 50; Lung Neoplasms; Mice, Nude; Models, Molecular; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-ret; Quinolones; src-Family Kinases; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |